UpGuard's Cyber Security Ratings range from 0 to 950. The higher the score, the more likely Asterias Biotherapeutics is implementing good security practices.
BioTime, Inc. is a clinical-stage biotechnology company headquartered in Alameda, California. BioTime stock is traded on the New York Stock Exchange American Exchange under ticker symbol BTX. BioTime focuses primarily on aesthetics, ophthalmology and cell and drug delivery. The company is in clinical trials for dry age-related macular degeneration (dry AMD) and facial lipoatrophy in HIV patients.
This report shows a preliminary security rating for Asterias Biotherapeutics. UpGuard scans billions of digital assets daily, in depth, across thousands of vectors. Data leak detection, vulnerability scanning and identity breach detection are just some of the advanced capabilities offered by the UpGuard platform.Get a deeper scan →
Read more about the latest issues in cybersecurity
DMARC (Domain-based Message Authentication, Reporting & Conformance) is an email authentication ...
The Consensus Assessments Initiative Questionnaire (CAIQ) is a security assessment provided by the ...
Compare Asterias Biotherapeutics's security performance with other companies